Pulse on MedTech: How the industry is reigniting growth and expanding markets

The MedTech sector continues outperforming the S&P 500 after underperforming in previous years. The reversal in MedTech’s performance is partially due to advancements in technology, healthcare delivery efficiency and MedTech’s increasing role in this transformation.

The latest EY Pulse of the MedTech Industry Report examines five driving forces that are fully impacting MedTech, and in a panel discussion, we will more deeply explore these evolving discoveries.

By understanding trends and leadership perspectives, attendees will be better prepared to navigate the complexities of the industry and position their organizations for future success.

Panelists:

• John Babitt, EY Global MedTech Leader
• Finn Haley, Chief Business Development Officer – GE HealthCare
• Eric Schantz, VP of Corporate Development - Medtronic
• John Heinbigner, Partner, Life Sciences, EY-Parthenon, Ernst & Young LLP
• Jay Zhu, Principal, MedTech Strategy, Transactions and Commercial, EY-Parthenon, Ernst & Young LLP

Discussion points include:

• Earn your return: Total shareholder returns are strongly correlated with the successful (or failed) investment of capital into innovation and M&A.
• M&A integration is paramount: The successful integration of high-growth acquisitions is a competitive advantage. Focus on investing in commercial and R&D.
• Efficient organizational design and alignment: Evidence suggests that high-growth organizations thrive under a business unit–based operating model structure.
• Tariff mitigation strategy: Uncertainty persists in the global business environment. Companies must adapt to the shifting landscape with a multifunctional tariff task force.
• Technology and artificial intelligence accelerate strategy: New markets are evolving with operational efficiencies to improve supply chains - front-office and back-office applications.